GlaxoSmithKline PLC Director/PDMR Shareholding (7719C)
April 19 2017 - 11:14AM
UK Regulatory
TIDMGSK
RNS Number : 7719C
GlaxoSmithKline PLC
19 April 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr B McNamara
=== ======================== ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial I
instrument SIN: US37733W1053
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 April 2017 on ADSs held
in the Company's 2009 Performance Share
Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$41.81 90.871
--------- ----------
$41.81 454.207
--------- ----------
$41.81 701.005
--------- ----------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
1,246.083
$41.81
=== ======================== ===============================================
e) Date of the transaction 2017-04-18
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr D E Troy
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 April 2017 on ADSs held
in the Company's 2009 Performance Share
Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$41.81 1,237.606
--------- ----------
$41.81 1,435.850
--------- ----------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
2,673.456
$41.81
=== ======================== ===============================================
e) Date of the transaction 2017-04-18
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEKLFFDZFFBBB
(END) Dow Jones Newswires
April 19, 2017 11:14 ET (15:14 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
